Send feedback

RNF168 p.Pro401Gln

c.1202C>A · rs3796129 · VCV403381

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 7 submitters
AlphaMissense
likely benign
0.1376 · ACMG-weighted
gnomAD v4.1
Common
common (popmax 62.2%, nfe) — too common for a highly-penetrant pathogenic allele
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
RIDDLE syndrome

Computational evidence

Protein change
AlphaMissense0.1376likely benign
REVEL0.059moderately benign-leaning
SaProtLLR -6.08tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.4GERP 1, phastCons 1
Regional constrainto/e 1.06unconstrained · MANE · 31 kb · p 0.1 · regional, not allelic
Overall
CADD15.37PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 62.2% European (non-Finnish) · 733,467/1,179,684 alleles
Filtering AF 62.1% ClinGen BA1/BS1 input FAF95, joint · FAF99 62%
Overall 58.6% 945,363/1,613,568 alleles · common
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 66.4% 2
Amishnot grpmax-eligible 64.7% 2
European (non-Finnish)grpmax 62.2% 2
South Asian 62% 2
Ashkenazi Jewishnot grpmax-eligible 61.5% 2
Middle Eastern 60.8% 2
Remaining individualsnot grpmax-eligible 57.7% 2
Admixed American 41.5% 2
African / African-American 29.6% 3
East Asian 16.4% 6

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
RNF168
Protein
p.Pro401Gln
Coding
c.1202C>A
MANE Select
NM_152617
dbSNP
rs3796129
Type
single nucleotide variant
Location
chr3:196472333 (GRCh38)
Gene constraint
LOEUF 1.406 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 61.97 · 39 PDB
Residue 401
a UniProt-annotated variant site (in); the 'disordered' region
Full RNF168 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/rnf168-p-pro401gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown